Inflammation in mid-life as a predictor of mobility decline in older age

In a recent study published in the Journal of the American Geriatric Society, having high inflammation in mid-life was associated with a clinically meaningful slower gait speed-;an indicator of mobility-;20 years later.

In the study, which included 4,758 community-dwelling adults, the link between high inflammation and slower late-life gait speed was especially strong for people with sustained high inflammation over the 20-plus years of follow-up. The association was evident even among the healthiest adults who never experienced other common conditions such as obesity, hypertension, or diabetes.

These findings suggest that monitoring inflammation has the potential to be important for late life health, similar to monitoring routine health metrics such as blood pressure and glucose."

B. Gwen Windham, MD, MHS., corresponding author

Source:
Journal reference:

Parker, K. G., et al. (2024) Associations of mid-to-late-life inflammation with late-life mobility and the influences of chronic comorbidities, race, and social determinants of health: The Atherosclerosis Risk in Communities StudyJournal of the American Geriatrics Society. doi.org/10.1111/jgs.18978.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals refined carbs heighten inflammation and cardiovascular risk